INSIGHTS ON DRUG DEVELOPMENT

• How CRISPR And LNP Accelerate Therapeutic Innovation Through Analytics

  CRISPR gene editing and lipid nanoparticle delivery are revolutionizing precision medicine. Discover how optimized LNP systems and advanced analytics accelerate therapeutic development.

• Organ-Chips Outperform Animal Models And Spheroids

  Examine how 780 human Liver-Chips were assessed for their ability to predict drug-induced liver injury from small molecules.

• Simplify Your Cell Culture Processes

  Discover bioreactors that combine fast setup, robust design, and scalable performance to streamline cell culture workflows, which help you move from uncertainty to control, no matter your molecule.

• Solving Bioavailability Challenges In bRo5 Drugs

  Leverage mechanistic, material-sparing formulation strategies to enhance bioavailability and accelerate development of challenging bRo5 small molecules, even with limited resources.

• Use Of Spray Drying In Pharmaceutical Product Development

  10/21/2024

  Through this detailed exploration, participants will gain valuable knowledge on how to leverage spray drying to optimize drug development and delivery.

• The 5 Ws Of A Human Factors Strategy

  3/31/2025

  A human factors strategy ensures medical products are safe, effective, and compliant by integrating user-focused design early, reducing risks, and optimizing regulatory approval processes.

• Considerations In Design And Development Of Novel Combination Drug-Delivery Devices

  7/17/2026

  Poor scoping kills drug delivery device programs before they start. Learn how to define the right problem, assess risk early, and set boundaries that protect your timeline and budget.

• Inside Bioprocessing: Continuous Perfusion

  11/4/2025

  Learn about the essential elements of upstream workflows, media optimization strategies, and liquid handling logistics required to implement continuous perfusion successfully.

• Biocatalysis 101: Faster, Greener API Manufacturing

  4/20/2026

  View how enzyme-driven reactions accelerate pharmaceutical ingredient manufacturing, improve selectivity, reduce waste, lower costs, and support scalable, sustainable processes under mild conditions.